athenahealth, Inc. (NASDAQ:ATHN) had its target price cut by Wells Fargo & Company from $190.00 to $155.00 in a note issued to investors on Monday. The firm presently has an “outperform” rating on the health services provider’s stock. Wells Fargo & Company’s price objective suggests a potential upside of 22.30% from the stock’s current price.

A number of other equities research analysts have also issued reports on the stock. Canaccord Genuity reissued a “hold” rating and set a $123.00 target price (down previously from $144.00) on shares of athenahealth in a research note on Monday. First Analysis raised shares of athenahealth from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $125.00 to $127.00 in a research note on Monday. Robert W. Baird reissued a “buy” rating and set a $155.00 target price (down previously from $170.00) on shares of athenahealth in a research note on Sunday. Royal Bank Of Canada set a $144.00 target price on shares of athenahealth and gave the company a “hold” rating in a research note on Friday. Finally, Oppenheimer Holdings, Inc. reissued a “buy” rating and set a $184.00 target price on shares of athenahealth in a research note on Friday. Two research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and eleven have assigned a buy rating to the company’s stock. athenahealth presently has an average rating of “Hold” and a consensus price target of $144.91.

Shares of athenahealth (ATHN) traded up 0.46% during trading on Monday, reaching $126.62. The company had a trading volume of 929,501 shares. The stock has a 50 day moving average of $125.37 and a 200 day moving average of $130.33. The stock has a market capitalization of $5.06 billion, a price-to-earnings ratio of 160.69 and a beta of 1.76. athenahealth has a 52-week low of $90.11 and a 52-week high of $158.66.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.06. The company had revenue of $304.60 million during the quarter, compared to analyst estimates of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.94%. The company’s revenue for the quarter was up 10.1% on a year-over-year basis. During the same quarter last year, the business posted $0.60 EPS. Equities research analysts forecast that athenahealth will post $1.97 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/23/wells-fargo-company-trims-athenahealth-inc-athn-target-price-to-155-00.html.

In other news, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $140.01, for a total transaction of $112,008.00. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Jonathan D. Porter sold 300 shares of the business’s stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $142.88, for a total transaction of $42,864.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,783 shares of company stock worth $2,132,924. Insiders own 3.20% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Fox Run Management L.L.C. bought a new position in shares of athenahealth during the 3rd quarter worth about $460,000. Rockefeller Financial Services Inc. increased its holdings in shares of athenahealth by 293.2% during the 3rd quarter. Rockefeller Financial Services Inc. now owns 9,110 shares of the health services provider’s stock worth $1,133,000 after purchasing an additional 6,793 shares during the period. Toronto Dominion Bank bought a new position in shares of athenahealth during the 2nd quarter worth about $16,863,000. 1st Global Advisors Inc. bought a new position in shares of athenahealth during the 2nd quarter worth about $243,000. Finally, Verition Fund Management LLC bought a new position in shares of athenahealth during the 2nd quarter worth about $272,000.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.